Australia’s new medical guidance backs conditional puberty blocker access but two regions keep bans
A group of people holding trans flags. (Getty Images)
Queensland and the Northern Territory say they will keep their public-hospital bans on puberty blockers for trans and gender-diverse under-18s, despite new national medical guidance backing conditional access.
Australia’s National Health and Medical Research Council (NHMRC) released interim national clinical practice guidelines on Monday (16 November) advising the use of puberty blockers for gender incongruence in children in certain circumstances.
Queensland health minister Tim Nicholls said the state’s stance would not shift. “Our position remains unchanged and we will continue to prioritise the health, safety and wellbeing of young Queenslanders,” he said. In a statement, the Northern Territory government also said its ban would remain in place, despite the NHMRC advice.
What does the NHMRC interim advice recommend?
The NHMRC’s interim advice recommends puberty blockers remain an option in certain circumstances, with a strong emphasis on shared decision-making between young people, their parents or carers, and clinicians.
“Shared decision-making involves young people, their parents or carers and clinicians discussing the available evidence, potential benefits and harms, and the young person’s individual circumstances and preferences before deciding together whether treatment is appropriate,” the NHMRC said.

The guidance also rejected a “wait and see” approach as a form of withholding care, saying it “can affect the young person’s physical and mental health, wellbeing, and ability to function”.
The NHMRC is Australia’s leading national body for funding health and medical research and developing evidence-based health guidance. Its advice can shape clinical and political debates, but it does not automatically change state and territory health policy.
Why can Queensland and the NT keep their bans?
Federal health minister Mark Butler said the bans were matters for the Queensland and Northern Territory governments and the commonwealth could not intervene, but he expected jurisdictions to take the NHMRC’s view seriously. “I am very confident that every state government, no matter their political persuasion, will consider the advice of our pre-eminent authority very closely,” he said.
Queensland’s restrictions have already been through the courts. In October 2025, Queensland reinstated its puberty blocker ban hours after the supreme court overturned it, after judge Peter Callaghan said officials had failed to properly consult relevant authorities before the original directive was announced.
Public consultation on the NHMRC’s interim advice is open until 18 January, 2027. Full guidelines addressing other aspects of care, including gender-affirming hormones, are expected to be available in 2028.